LeMaitre Vascular Inc LMAT.OQ reported quarterly adjusted earnings of 60 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 52 cents. The mean expectation of eleven analysts for the quarter was for earnings of 57 cents per share. Wall Street expected results to range from 55 cents to 58 cents per share.
Revenue rose 15% to $64.23 million from a year ago; analysts expected $62.48 million.
LeMaitre Vascular Inc's reported EPS for the quarter was 60 cents.
The company reported quarterly net income of $13.78 million.
LeMaitre Vascular Inc shares had risen by 1.6% this quarter and lost 8.4% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts was unchanged in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 6 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for LeMaitre Vascular Inc is $108.00, about 21.9% above its last closing price of $84.36
This summary was machine generated from LSEG data August 5 at 09:01 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)